Completed NA INTERVENTIONAL 2-arm NCT01080443

Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule Under Fasting Condition

Open Label Balanced Randomized Two-treatment Two-period Two-sequence Single Dose Two-way Crossover Oral Bioequivalence Study of Mycophenolate Mofetil Capsules 250 mg in Normal Healthy Adult Human Subjects Under Fasting Conditions

Sponsor: Panacea Biotec Ltd

Conditions Healthy Volunteers

Interventions Mycophenolate Mofetil Capsule 250 mg

Updated 6 times since 2017 Last updated: Mar 11, 2010 Started: Jun 30, 2008 Primary completion: Jul 31, 2008 Completion: Jul 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01080443, this NA trial focuses on Healthy Volunteers and remains completed. Sponsored by Panacea Biotec Ltd, it has been updated 6 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Feb 2017 — Jun 2018 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Jun 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Panacea Biotec Ltd

Data source: Panacea Biotec Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ahmedabad, India